Prestige Consumer Healthcare Inc.

NYSE:PBH

Sector

🛍 Consumer Discretionary

Industries

🧴 Personal Care

💄 Cosmetics

💊 Drugstores & Retail Pharmacies

🛍 Specialty Retail

Location

United States

Market Cap

USD 4.04 B

Share Price

USD 81.15

Avg Daily Volume

381,522

Change (1 day)

-0.72%

Change (1 year)

17.78%

Change (YTD)

3.92%

Prestige Consumer Healthcare Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2025: USD 0.00

Prestige Consumer Healthcare Inc. Research and Development (R&D) Expenses is USD 0.00 for the Trailing 12 Months (TTM) ending March 31, 2025. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.

Prestige Consumer Healthcare Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 0.00.
Prestige Consumer Healthcare Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 0.00.
Prestige Consumer Healthcare Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 0.00.
Prestige Consumer Healthcare Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.00.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Research and Development (R&D) Expenses	Revenue	Revenue	Gross Profit

NYSE: PBH

Prestige Consumer Healthcare Inc.

CEO	Ms. Christine Sacco CPA
IPO Date	Feb. 10, 2005
Location	United States
Headquarters	660 White Plains Road
Employees	600
Sector	🛍 Consumer Discretionary
Industries Personal Care 💄 Cosmetics 💊 Drugstores & Retail Pharmacies 🛍 Specialty Retail

Description

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.